Overview
Updated 14 Jul 2026
Gareth Morgan, MD, is Director, Multiple Myeloma Research, Perlmutter Cancer Center at NYU Langone Health / NYU Grossman School of Medicine (Perlmutter Cancer Center). The public record shows 1,922 publications with 72,482 citations (h-index 126), centered on Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 11 companies, 1 NIH-funded awards (2021–2025).
- Most recent indexed publication: 2026 · Blood cancer discovery
- Top research focus: Multiple Myeloma Research and Treatments
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 33 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 665.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHL
Sponsor: Acrotech Biopharma Inc.
InvestigatorPhase 1/PHASE2CompletedNCT01851551 - Cardiac GSI Feasibility Study
Sponsor: University Hospital Plymouth NHS Trust
InvestigatorCompletedNCT01816750 - Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)
Sponsor: Chroma Therapeutics
InvestigatorPhase 1/PHASE2CompletedNCT00689000
Industry payments
Updated 14 Jul 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20258 payments
- GENZYME CORPORATIONProgram year20251 payment
- Janssen Research & Development, LLCProgram year20252 payments
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 2021–2025 per NIH RePORTER. The latest:
- Role of the Environment, Mutographs and T Cell Immunity on MGUS
University of Alabama at Birmingham
FY2026$497,385R01CA300518 - Mutographs differentiating the inheritance and temporal onset of multiple myeloma
New York University School of Medicine
FY2025$1,127,014R01CA249981 - Role of Disadvantage, Mutographs and T Cell Immunity on MGUS in African Americans
University of Alabama at Birmingham
FY2025$509,510R01CA300518
Congress activity
Updated 14 Jul 2026
143 congress contributions (1997–2025) across AACR, ASCO, ASH, ESMO per OpenAlex. The most recent:
- Chromothripsis drives high-risk multiple myeloma by copy number abnormalities and rewiring the epigenome to activate oncogenic programs.
ASH Annual Meeting
ASH2025Co-author - Genomics define neoplastic transformation in multiple myeloma precursor conditions
ASH Annual Meeting
ASH2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Genomic features do not account for differences in multiple myeloma risk by ancestry.
Blood cancer discovery
2026 - Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.
Blood cancer discovery
2025
Most-cited worksby citation count (OpenAlex)
- 02
- 03International Staging System for Multiple Myeloma2,919 citations2005
- 04International uniform response criteria for multiple myeloma2,642 citations2006
- 05
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
240 East 38th Street, 19th Floor, New York, NY 10016
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- FRCP
Fellow of the Royal College of Physicians (London)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - FRCPath
Fellow of the Royal College of Pathologists
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →patientpower.info ↗
Editorial & leadership rolesjournal and society appointments
- Editorial Board Member
Clinical Cancer Research (AACR journal)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aacrjournals.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.uams.edu ↗
Secondary affiliationsappointments beyond the home institution
- Formerly Director
Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences (UAMS); Deputy Director, Winthrop P. Rockefeller Cancer Institute
2019verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →news.uams.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →news.uams.edu ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthtree.org ↗
- Video Journal of Hematological Oncology (VJHemOnc)
recurring contributor, multiple video discussions on myeloma trials/genetics (e.g. Myeloma XI outcomes)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vjhemonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/gareth-morgan-md-04995cde
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - X / Twitter
x.com/DrGarethMorgan1
Mentions by otherswhere others cite or feature them
- Other
nyulangone.org/news/leading-myeloma-experts-join-new-center-blood-cancers-nyu-langone-health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ira Jacobson, MD
NYU Langone Health
- 594
- publications
- 87
- h-index
- 4
- trials
Mario Lacouture, MD
NYU Langone Health
- 703
- publications
- 88
- h-index
- 11
- trials
Gregory Haber, MD
NYU Langone Health
- 286
- publications
- 39
- h-index
- 8
- trials
Larry Chinitz, MD
NYU Langone Health
- 297
- publications
- 35
- h-index
- 8
- trials